HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.90+0.05 (+0.34%)
Close on Nov 13, 2026Market cap $2.60BP/E 5.7Yield –
HUTCHMED (China) profit margin
Profit margin (net margin) is net income as a percentage of revenue.
HUTCHMED (China)'s profit margin for the twelve months ending Dec 31, 2019 was -51.7%. For fiscal 2025 it was 83.3%, against 6.0% the year before. The highest annual figure on record is 83.3% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 83.3% | +77.3 |
| FY2024 | Dec 31, 2024 | 6.0% | −6.0 |
| FY2023 | Dec 31, 2023 | 12.0% | +96.6 |
| FY2022 | Dec 31, 2022 | -84.6% | −30.0 |
| FY2021 | Dec 31, 2021 | -54.7% | +0.5 |
| FY2020 | Dec 31, 2020 | -55.2% | −3.4 |
| FY2019 | Dec 31, 2019 | -51.7% | −16.8 |
| FY2018 | Dec 31, 2018 | -34.9% | −23.9 |
| FY2017 | Dec 31, 2017 | -11.1% | −16.5 |
| FY2016 | Dec 31, 2016 | 5.4% | +0.9 |
| FY2015 | Dec 31, 2015 | 4.5% | +12.9 |
| FY2014 | Dec 31, 2014 | -8.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -55.4% | −24.3 |
| Q3 FY2019 | Sep 30, 2019 | -63.0% | −19.5 |
| Q2 FY2019 | Jun 30, 2019 | -50.9% | −8.9 |
| Q1 FY2019 | Mar 31, 2019 | -38.1% | −15.7 |
| Q4 FY2018 | Dec 31, 2018 | -31.1% | – |
| Q3 FY2018 | Sep 30, 2018 | -43.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -42.0% | – |
| Q1 FY2018 | Mar 31, 2018 | -22.4% | – |
See a number that looks wrong?